JHP Pharmaceuticals has entered into a multi-year contract supply agreement with an undisclosed ophthalmic company. Under terms of the agreement, JHP will manufacture and supply an ophthalmic product, which is scheduled to launch next year.

Stuart Hinchen, co-founder and president of JHP, stated, “We are very pleased that JHP was chosen for this large-scale multi-year contract. Our knowledgeable staff, approach to technology transfer and cGMP compliance record with the FDA, EMEA and ANVISA allows us to serve this important customer. We have a long history of successful partnerships, manufacturing both commercial products and products in development with experience taking products from clinical trial supplies to commercial manufacturing.”